Skip to main content
. Author manuscript; available in PMC: 2012 May 12.
Published in final edited form as: Cell Immunol. 2011 May 12;270(2):188–197. doi: 10.1016/j.cellimm.2011.05.007

Figure 4.

Figure 4

Effect of DC/mBORIS vaccine on metastatic tumor development. Pie charts depict the percentage of animals that had persistent tumor at 22 days with or without the presence of clonogenic lung metastases and the percentage of animals without persistent tumor and without lung metastases. Of note, no animals with eradication of the primary tumor were demonstrated to have lung metastases. The table depicts the range of distribution of number of clonogenic lung metastases present in the animals from the various treatment cohorts.